vTv Therapeutics (VTVT) Total Non-Current Liabilities (2014 - 2022)

vTv Therapeutics (VTVT) has 9 years of Total Non-Current Liabilities data on file, last reported at $13.1 million in Q1 2022.

• For the quarter ending Q1 2022, Total Non-Current Liabilities rose 27.19% year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2022 stood at $13.1 million (up 27.19% YoY), and the FY2021 full-year result was $9.0 million, down 17.87% from the prior year.
• Total Non-Current Liabilities climbed to $13.1 million in Q1 2022, from $9.0 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $43.2 million in Q2 2018 to a low of $8.3 million in Q3 2021.
• A 5-year average of $19.9 million and a median of $16.8 million in 2020 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities soared 44.95% in 2018 and plunged 49.82% in 2019, its largest moves.
• Tracing VTVT's Total Non-Current Liabilities over 5 years: stood at $28.7 million in 2018, then plunged by 37.75% to $17.8 million in 2019, then sank by 38.66% to $10.9 million in 2020, then decreased by 17.87% to $9.0 million in 2021, then jumped by 46.17% to $13.1 million in 2022.
• Business Quant data shows VTVT's Total Non-Current Liabilities at $13.1 million in Q1 2022, $9.0 million in Q4 2021, and $8.3 million in Q3 2021.